Similar articles

• Nonabsorbable disaccharides for hepatic encephalopathy.

  Als-Nielsen B, Gluud LL, Gluud C. Als-Nielsen B, et al. Cochrane Database Syst Rev. 2004;(2):CD003044. doi: 10.1002/14651858.CD003044.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2016 Apr 18;4:CD003044. doi: 10.1002/14651858.CD003044.pub3. PMID: 15106187 Updated.
• Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?

  Capocaccia L, Riggio O. Capocaccia L, et al. Hepatology. 1990 Aug;12(2):368-70. doi: 10.1002/hep.1840120228. Hepatology. 1990. PMID: 2391075 No abstract available.
• Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.

  Morgan MY. Morgan MY. Metab Brain Dis. 2016 Dec;31(6):1361-1364. doi: 10.1007/s11011-016-9910-2. Epub 2016 Sep 16. Metab Brain Dis. 2016. PMID: 27638474 Free PMC article. Review.
• Disaccharides in the treatment of hepatic encephalopathy.

  Sharma P, Sharma BC. Sharma P, et al. Metab Brain Dis. 2013 Jun;28(2):313-20. doi: 10.1007/s11011-013-9392-4. Epub 2013 Mar 2. Metab Brain Dis. 2013. PMID: 23456517 Review.
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

  Als-Nielsen B, Gluud LL, Gluud C. Als-Nielsen B, et al. BMJ. 2004 May 1;328(7447):1046. doi: 10.1136/bmj.38048.506134.EE. Epub 2004 Mar 30. BMJ. 2004. PMID: 15054035 Free PMC article.